ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,917.11
0.00%
Dow Jones
43,408.47
0.32%
US Dollar vs MXN
20.3545
0.36%
Brent Oil
73.55
0.97%
Bitcoin
97,643.18
3.48%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Reino Unido
  5. LSE
  6. Skinbiotherapeutics Plc (SBTX)

  7. Skinbiotherapeutics Plc (SBTX) Noticias

SBTX

Skinbiotherapeutics (SBTX)

Skinbiotherapeutics Plc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:LSE:SBTX
FechaHoraFuenteTítuloSímboloCompañía
19/11/202401:00RNS Regulatory NewsSkinBioTherapeutics PLC Finalisation of commercial agreement with CrodaLSE:SBTXSkinbiotherapeutics Plc
25/10/202410:29RNS Regulatory NewsSkinBioTherapeutics PLC Holding(s) in CompanyLSE:SBTXSkinbiotherapeutics Plc
23/10/202410:34Alliance NewsAlliance NewsIN BRIEF: SkinBioTherapeutics boosts financial 2025 turnover forecastLSE:SBTXSkinbiotherapeutics Plc
23/10/202408:40RNS Regulatory NewsSkinBioTherapeutics PLC Integration update and share price movementLSE:SBTXSkinbiotherapeutics Plc
16/10/202401:00RNS Regulatory NewsSkinBioTherapeutics PLC Issue of Equity and Total Voting RightsLSE:SBTXSkinbiotherapeutics Plc
11/10/202401:00RNS Regulatory NewsSkinBioTherapeutics PLC Acquisition and Financial UpdateLSE:SBTXSkinbiotherapeutics Plc
04/10/202408:02RNS Regulatory NewsSkinBioTherapeutics PLC Notice of Investor Meet Company PresentationLSE:SBTXSkinbiotherapeutics Plc
19/09/202401:00RNS Regulatory NewsSkinBioTherapeutics PLC Final testing of SkinBiotix by Croda completedLSE:SBTXSkinbiotherapeutics Plc
02/08/202407:43Alliance NewsAlliance NewsSkinBioTherapeutics lands GBP1.6 million investment to support growthLSE:SBTXSkinbiotherapeutics Plc
02/08/202401:00RNS Regulatory NewsSkinBioTherapeutics PLC Investment of £1.56m from new investorsLSE:SBTXSkinbiotherapeutics Plc
29/07/202408:46Alliance NewsAlliance NewsSkinBio says trading "better than expected" as revenue growsLSE:SBTXSkinbiotherapeutics Plc
29/07/202401:01RNS Regulatory NewsSkinBioTherapeutics PLC Appointment of Senior Croda VP as Board AdvisorLSE:SBTXSkinbiotherapeutics Plc
29/07/202401:00RNS Regulatory NewsSkinBioTherapeutics PLC Full year trading updateLSE:SBTXSkinbiotherapeutics Plc
23/07/202409:00Alliance NewsAlliance NewsREPEAT: SkinBio announces closure of its convertible bond facilityLSE:SBTXSkinbiotherapeutics Plc
23/07/202408:59Alliance NewsAlliance NewsSkinBio announces closure of its convertible bond facilityLSE:SBTXSkinbiotherapeutics Plc
23/07/202401:00RNS Regulatory NewsSkinBioTherapeutics PLC Closure of Convertible Bond FacilityLSE:SBTXSkinbiotherapeutics Plc
22/07/202401:00RNS Regulatory NewsSkinBioTherapeutics PLC Conversion Notice and Total Voting RightsLSE:SBTXSkinbiotherapeutics Plc
15/07/202401:00RNS Regulatory NewsSkinBioTherapeutics PLC Notice of Business Update & Investor PresentationLSE:SBTXSkinbiotherapeutics Plc
18/06/202410:37Alliance NewsAlliance NewsEARNINGS AND TRADING: Cordel thrilled by Middle East contract winLSE:SBTXSkinbiotherapeutics Plc
18/06/202401:00RNS Regulatory NewsSkinBioTherapeutics PLC AxisBiotix Acne study reports positive dataLSE:SBTXSkinbiotherapeutics Plc
05/04/202401:00RNS Regulatory NewsSkinBioTherapeutics PLC Conversion Notice & Total Voting RightsLSE:SBTXSkinbiotherapeutics Plc
22/03/202406:34Alliance NewsAlliance NewsSkinBioTherapeutics half-year revenue jumps on UK-based salesLSE:SBTXSkinbiotherapeutics Plc
22/03/202402:00RNS Regulatory NewsSkinBioTherapeutics PLC Half-year ReportLSE:SBTXSkinbiotherapeutics Plc
18/03/202409:17Alliance NewsAlliance NewsSkinBioTherapeutics announces research into wound healing bacteriumLSE:SBTXSkinbiotherapeutics Plc
18/03/202402:00RNS Regulatory NewsSkinBioTherapeutics PLC New research project and CSO to return to academiaLSE:SBTXSkinbiotherapeutics Plc
08/03/202403:43RNS Regulatory NewsSkinBioTherapeutics PLC Notice of ResultsLSE:SBTXSkinbiotherapeutics Plc
28/02/202414:31Alliance NewsAlliance NewsTRADING UPDATES: Avacta plans fundraise to fund clinical developmentLSE:SBTXSkinbiotherapeutics Plc
28/02/202406:41RNS Regulatory NewsSkinBioTherapeutics PLC Conversion notice and alternative financingLSE:SBTXSkinbiotherapeutics Plc
27/02/202411:42Alliance NewsAlliance NewsTRADING UPDATES: Windward extends LSEG pact; Vinanz eyes DTC tradingLSE:SBTXSkinbiotherapeutics Plc
27/02/202401:00RNS Regulatory NewsSkinBioTherapeutics PLC Positive Interim AxisBiotix Acne study resultsLSE:SBTXSkinbiotherapeutics Plc
 Showing the most relevant articles for your search:LSE:SBTX

Su Consulta Reciente

USI
USTECH100
US Tech 100
NASDAQ
AAPL
Apple
NASDAQ
MSFT
Microsoft
COIN
DOGEUSD
Dogecoin
NYSE
MCD
McDonalds
USOTC
DTEGY
Deutsche Telekom (QX)
USOTC
BASFY
BASF (QX)
NYSE
MRK
Merck
NYSE
AXP
American Express
CCOM
US30
US 30
COIN
BTCUSD
Bitcoin
FX
EURMXN
Euro vs MXN
CCOM
OILBRENT
Brent Oil
NYSE
DIS
Walt Disney
NYSE
KO
Coca Cola
NYSE
VZ
Verizon Communications
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados